Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Author(s) Date Article Titlesort ascending Journal

Omar Abdel-Rahman

 February 2019 Impact of Diabetes on the Outcomes of Patients with Castration-Resistant Prostate Cancer Treated with Docetaxel: A Pooled Analysis of Three Phase III Studies Clinical Genitourinary Cancer

Omar Abdel-Rahman

 February 2018 Impact of baseline characteristics on outcomes of advanced HCC patients treated with sorafenib: a secondary analysis of a phase III study Journal of Cancer Research and Clinical Oncology

Omar Abdel-Rahman

 June 2020 Impact of Baseline Characteristics on Extensive-stage SCLC Patients Treated with Etoposide/Carboplatin; a Secondary Analysis of a Phase III Study The Clinical Respiratory Journal

Omar Abdel-Rahman and Hatim Karachiwala

 June 2019 Impact of age on toxicity and efficacy of 5-FU-based combination chemotherapy among patients with metastatic colorectal cancer; a pooled analysis of five randomized trials International Journal of Colorectal Disease

Aakanksha Khandelwal, Mace Rothenberg, Sean Khozin, Amanda C Guidon, Michael Dougan, Leyre Zubiri, Laura Petrillo, Meghan E Sise, Alexandra-Chloe Villani, Douglas B Johnson, Osama Rahma and Elad Sharon

 July 2021 Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data Journal for ImmunoTherapy of Cancer

Shalhout, Sophia Z.; Kaufman, Howard L.; Sullivan, Ryan J.; Lawrence, Donald; Miller, David M.

 June 2021 Immune Checkpoint Inhibition in Marjolin Ulcer: A Case Series Journal of Immunotherapy

Sebastian Pölsterl, Pankaj Gupta, Lichao Wang, Sailesh Conjeti, Amin Katouzian, Nassir Navab

 July 2017 Heterogeneous ensembles for predicting survival of metastatic, castrate-resistant prostate cancer patients F1000 Research

Sophia Z Shalhout, Farees Saqlain, Kayla Wright, Oladayo Akinyemi, David M Miller

 January 2022 Generalizable EHR-R-REDCap pipeline for a national multi-institutional rare tumor patient registry Jamia Open

Timothe Menard, Bjorn Koneswarakantha, Donato Rolo, Yves Barmaz, Leszek Popko, Rich Bowling

 December 2019 Follow‑Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under‑Reporting in Oncology Trials? Drug Safety

Omar Abdel-Rahman, Winson Y. Cheung

 January 2018 External validation of the prostascore model inpatients with metastatic hormone-sensitive prostate cancer recruited to the CHAARTED study BJU International

Xiang Yin, Pallavi S. Mishra-Kalyan, Rajeshwari Sridhara, Mark D. Stewart,Elizabeth A. Stuart, and Ruthanna C. Davi

 January 2022 Exploring the Potential of External Control Arms created from Patient Level Data: A case study in non-small cell lung cancer Journal of Biopharmaceutical Statistics

Kelsey H Natsuhara, Li Zhang, Christopher A Carlos, Hala T Borno

 April 2021 Evaluating predictors of renal injury with sorafenib in hepatocellular carcinoma: A multi-ethnic cohort study Journal of Onco-Nephrology

Julia Wilkerson, Kald Abdallah, Charles Hugh-Jones, Greg Curt, Mace Rothenberg, Ronit Simantov, Martin Murphy, Joseph Morrell, Joel Beetsch, Daniel J. Sargent, Howard I. Scher, Peter Lebowitz,, Richard Simon, Wilfred D. Stein, Susan E. Bates, Tito Fojo

 January 2017 Estimation of Tumour Regression and Growth Rates During Treatment in Patients with Advanced Prostate Cancer: A Retrospective Analysis The Lancet Oncology

Hiroyuki Saeki, Takuji Komeda, Risa Tanaka, Yuki Yamatani & Hironori Sakai 

 March 2022 Estimation of a Suitable Number of Patients for Selective Safety Data Collection (ICH E19 Draft Guideline): When is the Safety Profile of a Drug Well Characterized? Therapeutic Innovation & Regulatory Science

Pages